|
|
|||
|
| |||
|
| |||
|
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
You-Hong Fang, Bing-Ling Zhang, Chun-Xiao Chen, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China Jia-Guo Wu, Sir Run Run Shaw hospital of College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China Correspondence to: Chun-Xiao Chen, Department of gastroenterlogy, The First Affiliated Hospital of College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. chcx@zj139.com Telephone: +86-571-87236628 Fax: +86-571-87236628 Received: 2006-12-05 Accepted: 2007-03-26
Abstract Intestinal lymphangiectasia (IL) is a rare disease characterized by dilated lymphatic vessles in the intestinal wall and small bowel mesentery which induce loss of protein and lymphocytes into bowel lumen. Because it most often occurs in the intestine and cannot be detected by upper gastroendoscopy or colonoscopy, and the value of common image examinations such as X-ray and computerized tomography (CT) are limited, the diagnosis of IL is difficult, usually needing the help of surgery. Capsule endoscopy is useful in diagnosing intestinal diseases, such as IL. We here report a case of IL in a female patient who was admitted for the complaint of recurrent edema accompanied with diarrhea and abdominal pain over the last twenty years, and aggravated ten days ago. She was diagnosed by M2A capsule endoscopy as a primary IL and confirmed by surgical and pathological examination.
© 2007 The WJG Press. All rights reserved.
Key words: Intestinal lymphangiectasia; Capsule endoscopy; Hypoproteinemia; Lymphocytopenia; Edema; Surgery
Fang YH, Zhang BL, Wu JG, Chen CX. A primary intestinal lymphangiectasia patient diagnosed by capsule endoscopy and confirmed at surgery: A case report. World J Gastroenterol 2007; 13(15): 2263-2265
http://www.wjgnet.com/1007-9327/13/2263.asp
INTRODUCTION Intestinal lymphangiectasia (IL) is a rare disease and was first reported by Waldmanin in 1961[1]. Since then, no more than two hundred cases have been reported. IL can be classified into primary (idiopathic) and secondary type. Secondary IL is manifested as hypoproteinemia, lymphocytopenia and edema. IL has been found to be the cause of one third of protein-losing enteropathy patients. Main laboratory findings of this disease include decreased lymphocytes, serum protein and immunoglobin, increased fat concentration in stool. Common image examinations, such as lymphangiography, ECT examination, abdominal CT scan, are helpful. Endoscopy and capsule endoscopy can discover lesions which cannot be detected by gastroen-doscopy or colonoscopy. Pathological examination makes its definite diagnosis. Medium chain triglyceride (MCT) supplement can improve its clinical symptoms. It was reported that somatostatin and antiplasmin are effective in some cases[2]. Surgery can be performed to alleviate symptoms in patients with limited lesions or a large amount of ascites[3]. Treatment of secondary IL is focused on symptoms and etiology. IL can progress to lymphoma after years or decades. We here present a case of IL diagnosed by capsule endoscopy and confirmed at surgery.
CASE REPORT A 55-year old female was admitted to our hospital in March 2005 for recurrent edema accompanied with diarrhea and abdominal pain during the last twenty years, and aggravated ten days ago. The clinical findings are listed in Table 1. The patient denied other systemic diseases and any surgical history, as well as family history of such a disease. Other examinations (such as stool and urea examinations, serum tumor markers, purified protein derivatives (PPD) test, autoimmunity examinations) were all negative. Finally the patient underwent surgical exploration with resection of the affected intestine. Pathological examination confirmed the diagnosis of primary intestinal lymphangiectasia.
DISCUSSION IL is a rare disease characterized by dilated lymphatic vessles in the intestinal wall and small bowel mesentery which induce loss of protein and lymphocytes into bowel lumen. This disease is due to obstruction of the lymph drainage system with various causes. When the pressure of lymphatic vessels increases, the lymphatic vessels dilate and rupture, resulting in leakage of lymph fluid, which in turn, leads to hypoproteinemia, edema, and lymphocytopenia. Leakage of lymph fluid into the bowel lumen can result in celiac and steatorrhea and leakage of lymph fluid into the abdominal cavity can cause chyliform ascites. According to the cause of the disease, it can be classified into primary and secondary intestinal lymphangiectasia. Primary intes-tinal lymphangiectasia usually occurs in children and adolescents, due to deformity of the lymphatic system[1]. Adult intestinal lymphangiectasia is often secondary to many other factors, such as lymphoma, systemic lupus erythematosus (SLE), intestinal tuberculosis, retroperitoneal fibrosis, post-radiation effect[4], repeated parasite infection[5], hepatic cirrhosis[6], constrictive pericarditis, and abdominal surgery. The disease is characterized by hypoproteinemia, lym-phocytopenia, edema and ascites. Clinical manifestations may be presented as asymptomatic or fatigue, lower abdo-minal pain, edema, chylothorax, chronic diarrhea, ascites, recurrent intestinal bleeding with unknown reason, or protein-losing enteropathy, even as a surgical emergency with right abdominal pain, abdominal mass. Children may show growth retardation, smaller physical constitution. Iron deficiency anemia and hypocalcemic tetany can be observed too. Laboratory findings include decreased serum total protein and albumin along with decreased immunoglobulin levels including IgA, IgM, and especially IgG, due to its long half life. The number of lymphocytes, especially CD4+ and CD8+ lymphocytes, is decreased in almost every patient[7]. Secondary IL has other laboratory findings according to the primary disease. Diagnosis of this disease depends on characteristic features identified from gastroendoscopy and capsule endoscopy. Lymphangiography sometimes can find deformities of lymphatic vessels. ECT can indicate protein loss into the bowel lumen. Pathological examination confirms the final diagnosis. Since intestinal lymphangiectasia often occurs at jejunoileum[1,8], the upper and lower gastroendoscopy cannot access it in the intestine. If the lesion is within the reach of the endoscope, a biopsy would be diagnostic. Otherwise, lymphangiography or surgery is needed for a diagnosis. Capsule endoscopy is a relatively new technique, it is highly useful for evaluating small bowel diseases such as small bowel Crohn’s disease[9]. The manifestations of intestinal lymphangiectasia observed by capsule endoscopy have been reported[10]. Capsule endoscopy is a useful and noninvasive method to diagnose intestinal lymphangiectasia when other methods are in-capable of finding the lesion. Treatment of intestinal lymphangiectasia depends on different situations. Usually a low-fat, high-protein diet supplemented with medium-chain triglyceride (MCT) can improve the clinical symptoms and signs[11-13]. Essential trace elements need to be supplemented too. Both primary and secondary intestinal lymphangiectasia can follow this treatment with few side effects. However, patients may need to be treated in their whole life, because the symptoms and signs will recur soon after stopping the treatment. Medium-chain triglycerides, unlike the long-chain triglycerides, can bypass the lymphatic system and directly secreted into portal system, avoiding the increase of lymphatic vessel pressure and the loss of protein. It was reported that somatostatins such as octreotide can decrease triglyceride absorption[6,14]. Antiplasmin therapy may have some role when fibrinolysis is increased[15,16]. Isolated lesions should be resected. In this paper, we report a case of IL, mainly presented as protein-losing enteropathy. Capsule endoscopy is a good option for the diagnosis of intestinal diseases such IL.
REFERENCES 1 Waldmann TA, Steinfeld JL, Dutcher TF, Davidson JD, Gordon RS Jr. The role of the gastrointestinal system in "idiopathic hypoproteinemia". Gastroenterology 1961; 41: 197-207 PubMed 2 Stanley AJ, Gilmour HM, Ghosh S, Ferguson A, McGilchrist AJ. Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension. Gastroenterology 1996; 111: 1679-1682 3 Chen CP, Chao Y, Li CP, Lo WC, Wu CW, Tsay SH, Lee RC, Chang FY. Surgical resection of duodenal lymphangiectasia: a case report. World J Gastroenterol 2003; 9: 2880-2882 PubMed 4 Rao SS, Dundas S, Holdsworth CD. Intestinal lymphangiectasia secondary to radiotherapy and chemotherapy. Dig Dis Sci 1987; 32: 939-942 PubMed 5 Oksuzoglu G, Aygencel SG, Haznedaroglu IC, Arslan M, Bayraktar Y. Intestinal lymphangiectasia due to recurrent giardiasis. Am J Gastroenterol 1996; 91: 409-410 PubMed 6 Lee HL, Han DS, Kim JB, Jeon YC, Sohn JH, Hahm JS. Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report. J Korean Med Sci 2004; 19: 466-469 PubMed 7 Fuss IJ, Strober W, Cuccherini BA, Pearlstein GR, Bossuyt X, Brown M, Fleisher TA, Horgan K. Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol 1998; 28: 4275-4285 PubMed 8 Vardy PA, Lebenthal E, Shwachman H. Intestinal lymphagiec-tasia: a reappraisal. Pediatrics 1975; 55: 842-851 9 Seidman EG, Dirks MH. Capsule Endoscopy in the Pediatric Patient. Curr Treat Options Gastroenterol 2006; 9: 416-422 PubMed 10 Chamouard P, Nehme-Schuster H, Simler JM, Finck G, Baumann R, Pasquali JL. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia. Dig Liver Dis 2006; 38: 699-703 PubMed 11 Biselli M, Andreone P, Gramenzi A, Cursaro C, Lorenzini S, Bonvicini F, Bernardi M. Acquired intestinal lymphan- giectasia successfully treated with a low-fat and medium-chain triacylglycerol-enriched diet in a patient with liver transplantation. Eur J Gastroenterol Hepatol 2006; 18: 561-564 PubMed 12 Tift WL, Lloyd JK. Intestinal lymphangiectasia. Long-term results with MCT diet. Arch Dis Child 1975; 50: 269-276 13 Munoz Conde J, Gomez de Terreros I, Sanchez Ruiz F, Gavilan Carrasco F, Meneses Pardo AG. Idiopathic intestinal lymphangiectasis. Evolution with M.C.T. (author's transl) An Esp Pediatr 1976; 9: 438-446 PubMed 14 Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996; 334: 246-254 PubMed 15 Mine K, Matsubayashi S, Nakai Y, Nakagawa T. Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology 1989; 96: 1596-1599 PubMed 16 MacLean JE, Cohen E, Weinstein M. Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy. Pediatrics 2002; 109: 1177-1180 PubMed
S- Editor Liu Y L- Editor Wang XL E- Editor Liu Y
|
|
|
|
|
PubMed